The Alpha-Fetoprotein (AFP) Test at Pamel Laboratories is a specialized tumor marker test used to detect and monitor certain types of cancers, particularly liver cancer (hepatocellular carcinoma) and germ cell tumors of the ovaries or testicles. AFP is a protein normally produced by the liver and yolk sac of a developing fetus, but elevated levels in adults can indicate malignant growths or liver disease.
This test is also useful in monitoring cancer treatment response, detecting recurrence, and assessing risk in patients with chronic liver conditions like hepatitis or cirrhosis.
What the Test Measures:
-
The level of alpha-fetoprotein (AFP) in the blood
-
A biomarker used in cancer detection, treatment monitoring, and risk assessment
Purpose of the Test:
-
Diagnose or monitor:
-
Hepatocellular carcinoma (primary liver cancer)
-
Germ cell tumors (ovarian or testicular)
-
Metastatic cancers involving the liver
-
Liver cirrhosis or hepatitis-related liver damage
-
Evaluate response to:
Sample Type: Blood sample (serum)
Fasting Required: No
Turnaround Time: 1–2 working days
Interpretation Guide:
-
High AFP levels: May indicate liver cancer, germ cell tumors, or active liver disease
-
Mildly elevated AFP: Can occur in chronic hepatitis or liver cirrhosis
AFP results should always be interpreted in combination with imaging studies and clinical findings
